176 related articles for article (PubMed ID: 12183093)
1. Assessment of patient-reported clinical outcome in pancreatic and other hepatobiliary cancers: the FACT Hepatobiliary Symptom Index.
Yount S; Cella D; Webster K; Heffernan N; Chang C; Odom L; van Gool R
J Pain Symptom Manage; 2002 Jul; 24(1):32-44. PubMed ID: 12183093
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).
Butt Z; Parikh ND; Beaumont JL; Rosenbloom SK; Syrjala KL; Abernethy AP; Benson AB; Cella D
Cancer; 2012 Dec; 118(23):5997-6004. PubMed ID: 22605658
[TBL] [Abstract][Full Text] [Related]
3. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire.
Heffernan N; Cella D; Webster K; Odom L; Martone M; Passik S; Bookbinder M; Fong Y; Jarnagin W; Blumgart L
J Clin Oncol; 2002 May; 20(9):2229-39. PubMed ID: 11980994
[TBL] [Abstract][Full Text] [Related]
4. Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer.
Cella D; Butt Z; Kindler HL; Fuchs CS; Bray S; Barlev A; Oglesby A
Qual Life Res; 2013 Jun; 22(5):1105-12. PubMed ID: 22678353
[TBL] [Abstract][Full Text] [Related]
5. Symptom concerns and quality of life in hepatobiliary cancers.
Sun V; Ferrell B; Juarez G; Wagman LD; Yen Y; Chung V
Oncol Nurs Forum; 2008 May; 35(3):E45-52. PubMed ID: 18467279
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of the psychometric properties of disease-specific, quality-of-life questionnaires for patients with hepatobiliary or pancreatic cancers.
Tian L; Cao XY
Jpn J Nurs Sci; 2018 Apr; 15(2):99-112. PubMed ID: 29057615
[TBL] [Abstract][Full Text] [Related]
7. Assessment of symptom experience in patients undergoing hepatic resection or ablation.
Eid S; Stromberg AJ; Ames S; Ellis S; McMasters KM; Martin RC
Cancer; 2006 Dec; 107(11):2715-22. PubMed ID: 17075874
[TBL] [Abstract][Full Text] [Related]
8. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN).
Cella D; Paul D; Yount S; Winn R; Chang CH; Banik D; Weeks J
Cancer Invest; 2003; 21(4):526-35. PubMed ID: 14533442
[TBL] [Abstract][Full Text] [Related]
9. Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma.
Steel JL; Eton DT; Cella D; Olek MC; Carr BI
Ann Oncol; 2006 Feb; 17(2):304-12. PubMed ID: 16357021
[TBL] [Abstract][Full Text] [Related]
10. The expression of FOXL2 in pancreatic, hepatobiliary, and renal tumors with ovarian-type stroma.
Westerhoff M; Tretiakova M; Hart J; Gwin K; Liu X; Zhou M; Yeh MM; Antic T
Hum Pathol; 2014 May; 45(5):1010-4. PubMed ID: 24746205
[TBL] [Abstract][Full Text] [Related]
11. Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).
Yount S; Cella D; Banik D; Ashraf T; Shevrin D
Health Qual Life Outcomes; 2003 Nov; 1():69. PubMed ID: 14633279
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of Chinese version of the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire].
Zhu ZC; Lang QB; Chen Z; Li DT; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):341-5. PubMed ID: 18405598
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
Cella D; Yount S; Du H; Dhanda R; Gondek K; Langefeld K; George J; Bro WP; Kelly C; Bukowski R
J Support Oncol; 2006 Apr; 4(4):191-9. PubMed ID: 16669463
[TBL] [Abstract][Full Text] [Related]
14. Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study.
Chau I; Peck-Radosavljevic M; Borg C; Malfertheiner P; Seitz JF; Park JO; Ryoo BY; Yen CJ; Kudo M; Poon R; Pastorelli D; Blanc JF; Chung HC; Baron AD; Okusaka T; Bowman L; Cui ZL; Girvan AC; Abada PB; Yang L; Zhu AX
Eur J Cancer; 2017 Aug; 81():17-25. PubMed ID: 28591675
[TBL] [Abstract][Full Text] [Related]
15. Surgical and interventional palliative treatment of upper gastrointestinal malignancies.
Rice D; Geller A; Bender CE; Gostout CJ; Donohue JH
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):403-8. PubMed ID: 10783992
[TBL] [Abstract][Full Text] [Related]
16. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.
King MT; Stockler MR; Butow P; O'Connell R; Voysey M; Oza AM; Gillies K; Donovan HS; Mercieca-Bebber R; Martyn J; Sjoquist K; Friedlander ML
Int J Gynecol Cancer; 2014 Jun; 24(5):865-73. PubMed ID: 24844220
[TBL] [Abstract][Full Text] [Related]
17. FACT-Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status.
Gmür A; Kolly P; Knöpfli M; Dufour JF
Liver Int; 2018 Aug; 38(8):1468-1474. PubMed ID: 29389088
[TBL] [Abstract][Full Text] [Related]
18. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.
Cella D
Semin Hematol; 1997 Jul; 34(3 Suppl 2):13-9. PubMed ID: 9253779
[TBL] [Abstract][Full Text] [Related]
19. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.
George GC; Iwuanyanwu EC; Anderson KO; Yusuf A; Zinner RG; Piha-Paul SA; Tsimberidou AM; Naing A; Fu S; Janku F; Subbiah V; Cleeland CS; Mendoza TR; Hong DS
Cancer; 2016 Nov; 122(21):3401-3409. PubMed ID: 27412379
[TBL] [Abstract][Full Text] [Related]
20. Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Klein J; Dawson LA; Jiang H; Kim J; Dinniwell R; Brierley J; Wong R; Lockwood G; Ringash J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):16-25. PubMed ID: 26279020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
